Market Overview

Amneal Pharmaceuticals Reports Q2 Earnings Miss, Lowers Guidance


Amneal Pharmaceuticals (NYSE: AMRX) reported second-quarter earnings of 9 cents per share, which missed the analyst consensus estimate of 14 cents by 35.71%. This is a 62.5% decrease over earnings of 24 cents per share from the same period last year.

The company reported quarterly sales of $404.642 million, which missed the analyst consensus estimate of $428.58 million by 5.59%. This is a 2.21% decrease over sales of $413.787 million the same period last year.

Amneal Pharmaceuticals lowered its fiscal year 2019 EPS guidance from 94 cents-$1.04 to 52 cents-62 cents versus a 61 cent estimate.

Amneal Pharmaceuticals closed Friday at $3.25. The stock has a 52-week high of $24.48 and a 52-week low of $3.18.

Related Links:

Arconic Trades Higher On Q2 Earnings Beat, Raised Guidance

Sealed Air Reports Mixed Q2 Earnings, Raises Guidance

Posted-In: Earnings News Guidance


Related Articles (AMRX)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Univar Reports Q2 Earnings Miss

Jacobs Engineering Reports Q3 Earnings Beat